Purdue, Impax Settle IP Claims In OxyContin Antitrust MDL
Impax Laboratories Inc. has settled a suit alleging its proposed generic version of OxyContin infringed Purdue Pharma LP's patents for a tamper-resistant version of the painkiller, according to a consent judgment...To view the full article, register now.
Already a subscriber? Click here to view full article